ArticleNeuro-oncology advances
The PARP inhibitor Rucaparib synergizes with radiation to attenuate atypical teratoid rhabdoid tumor growth.
Irina Alimova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
cites it